341 related articles for article (PubMed ID: 26996163)
21. Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury.
Gong Z; Pan J; Shen Q; Li M; Peng Y
J Neuroinflammation; 2018 Aug; 15(1):242. PubMed ID: 30153825
[TBL] [Abstract][Full Text] [Related]
22. mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI.
Wen Y; Liu YR; Tang TT; Pan MM; Xu SC; Ma KL; Lv LL; Liu H; Liu BC
Int J Biochem Cell Biol; 2018 May; 98():43-53. PubMed ID: 29477360
[TBL] [Abstract][Full Text] [Related]
23. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
Shirasuna K; Karasawa T; Takahashi M
J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
[TBL] [Abstract][Full Text] [Related]
25. Retinal ischemia/reperfusion injury is mediated by Toll-like receptor 4 activation of NLRP3 inflammasomes.
Qi Y; Zhao M; Bai Y; Huang L; Yu W; Bian Z; Zhao M; Li X
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5466-75. PubMed ID: 25097240
[TBL] [Abstract][Full Text] [Related]
26. Sulforaphane alleviates retinal ganglion cell death and inflammation by suppressing NLRP3 inflammasome activation in a rat model of retinal ischemia/reperfusion injury.
Gong Y; Cao X; Gong L; Li W
Int J Immunopathol Pharmacol; 2019; 33():2058738419861777. PubMed ID: 31266422
[TBL] [Abstract][Full Text] [Related]
27. Artemisinin suppresses myocardial ischemia-reperfusion injury via NLRP3 inflammasome mechanism.
Wang F; Gao Q; Yang J; Wang C; Cao J; Sun J; Fan Z; Fu L
Mol Cell Biochem; 2020 Nov; 474(1-2):171-180. PubMed ID: 32729005
[TBL] [Abstract][Full Text] [Related]
28. PEDF Inhibits the Activation of NLRP3 Inflammasome in Hypoxia Cardiomyocytes through PEDF Receptor/Phospholipase A2.
Zhou Z; Wang Z; Guan Q; Qiu F; Li Y; Liu Z; Zhang H; Dong H; Zhang Z
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973457
[TBL] [Abstract][Full Text] [Related]
29. The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.
Jiang H; Gong T; Zhou R
Adv Immunol; 2020; 145():55-93. PubMed ID: 32081200
[TBL] [Abstract][Full Text] [Related]
30. Protective Effect of Ethyl Pyruvate against Myocardial Ischemia Reperfusion Injury through Regulations of ROS-Related NLRP3 Inflammasome Activation.
Jun JH; Shim JK; Oh JE; Shin EJ; Shin E; Kwak YL
Oxid Med Cell Longev; 2019; 2019():4264580. PubMed ID: 30728885
[TBL] [Abstract][Full Text] [Related]
31. Regulation of NLRP3 Inflammasome by Phosphorylation.
Song N; Li T
Front Immunol; 2018; 9():2305. PubMed ID: 30349539
[TBL] [Abstract][Full Text] [Related]
32. The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.
Gonçalves AC; Ferreira LS; Manente FA; de Faria CMQG; Polesi MC; de Andrade CR; Zamboni DS; Carlos IZ
Immunology; 2017 Jun; 151(2):154-166. PubMed ID: 28140444
[TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
34. Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashion.
Xie D; Guo H; Li M; Jia L; Zhang H; Liang D; Wu N; Yang Z; Tian Y
Basic Res Cardiol; 2023 Oct; 118(1):44. PubMed ID: 37814087
[TBL] [Abstract][Full Text] [Related]
35. Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes.
Gong T; Yang Y; Jin T; Jiang W; Zhou R
Trends Immunol; 2018 May; 39(5):393-406. PubMed ID: 29452983
[TBL] [Abstract][Full Text] [Related]
36. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
37. Artesunate Inhibits Renal Ischemia-Reperfusion-Mediated Remote Lung Inflammation Through Attenuating ROS-Induced Activation of NLRP3 Inflammasome.
Liu Z; Qu M; Yu L; Song P; Chang Y
Inflammation; 2018 Aug; 41(4):1546-1556. PubMed ID: 29730819
[TBL] [Abstract][Full Text] [Related]
38. Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion.
Kim HY; Kim SJ; Lee SM
FEBS J; 2015 Jan; 282(2):259-70. PubMed ID: 25327779
[TBL] [Abstract][Full Text] [Related]
39. Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.
An N; Gao Y; Si Z; Zhang H; Wang L; Tian C; Yuan M; Yang X; Li X; Shang H; Xiong X; Xing Y
Front Immunol; 2019; 10():1592. PubMed ID: 31354731
[TBL] [Abstract][Full Text] [Related]
40. Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Cardiac Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation.
Darwesh AM; Keshavarz-Bahaghighat H; Jamieson KL; Seubert JM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31319469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
